Company / R&D per Share
AIM ImmunoTech Inc. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$5.99
FY2025
5-year range
$0.14 / $5.99
FY2021-FY2025
Trend
+2588.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share changed +2588% YoY in FY2025, a notable deviation from the 9-year average annual change of +584%.
Based on SEC 10-K filings.
5.99 in FY2025 with a 5-year CAGR of +61.2%.
Improved from $0.15 to $5.99 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +234.6%
- 5-Year CAGR
- +61.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share increased 2588.1% year-over-year.
- Lowest r&d per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -71.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.99 | +2588.1% |
| FY2024 | $0.22 | +53.2% |
| FY2023 | $0.15 | -9.1% |
| FY2022 | $0.16 | +17.8% |
| FY2021 | $0.14 | -75.4% |
| FY2020 | $0.55 | -86.9% |
| FY2019 | $4.20 | +2790.1% |
| FY2018 | $0.15 | -56.3% |
| FY2017 | $0.33 | +34.2% |
| FY2016 | $0.25 | +528.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026